| Product Code: ETC8546828 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Netherlands saw a steady increase in pregabalin import shipments in 2024, with top exporting countries including Italy, India, China, Germany, and the UK. Despite moderate concentration indicated by the HHI, the compound annual growth rate (CAGR) from 2020 to 2024 was a promising 5.0%. The growth rate from 2023 to 2024 was particularly robust at 18.96%, suggesting a growing demand for pregabalin in the Dutch market. This trend reflects a positive outlook for the import market of pregabalin in the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Pregabalin Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Pregabalin Market - Industry Life Cycle |
3.4 Netherlands Pregabalin Market - Porter's Five Forces |
3.5 Netherlands Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Netherlands Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Netherlands Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in the Netherlands |
4.2.2 Growing awareness and acceptance of pregabalin as an effective treatment for neuropathic pain |
4.2.3 Rising geriatric population leading to higher demand for pain management medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for prescribing pregabalin in the Netherlands |
4.3.2 Competition from alternative pain management therapies impacting market growth |
5 Netherlands Pregabalin Market Trends |
6 Netherlands Pregabalin Market, By Types |
6.1 Netherlands Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Netherlands Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Netherlands Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Netherlands Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Netherlands Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Netherlands Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Netherlands Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Netherlands Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Netherlands Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Netherlands Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Pregabalin Market Import-Export Trade Statistics |
7.1 Netherlands Pregabalin Market Export to Major Countries |
7.2 Netherlands Pregabalin Market Imports from Major Countries |
8 Netherlands Pregabalin Market Key Performance Indicators |
8.1 Number of prescriptions for pregabalin by healthcare providers in the Netherlands |
8.2 Patient adherence rate to pregabalin treatment regimen |
8.3 Average time to market approval for new pregabalin formulations in the Netherlands |
9 Netherlands Pregabalin Market - Opportunity Assessment |
9.1 Netherlands Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Netherlands Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Netherlands Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Pregabalin Market - Competitive Landscape |
10.1 Netherlands Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |